Semaglutide and tirzepatide have similar purposes (treating type 2 diabetes), and both are administered as injections
The medication is not toxic to muscle tissue
Como el primer y nico agonista de los receptores de GIP y GLP-1 aprobado por la FDA, Mounjaro es una sola molcula que activa los receptores del cuerpo para el GIP y GLP-1, que son hormonas incretinas naturales.1 Mounjaro produjo reducciones de A1C superiores y consistentes respecto a los comparadores con los que se le evalu a travs del programa SURPASS, que fue diseado para estudiar la eficacia y seguridad de Mounjaro en un amplio rango de adultos con diabetes tipo 2, que podran ser tratados en la prctica clnica
It also lowers the risk of major cardiovascular events such as stroke, heart attack, or death in adults with type 2 diabetes who also have heart disease, and lowers the risk of worsening kidney disease, kidney failure (end-stage kidney disease), and death due to cardiovascular disease in adults with type 2 diabetes who also have chronic kidney disease
Frequently Asked Questions Here are answers to the questions patients most commonly ask about tirzepatides benefits and side effects
